Literature DB >> 25429721

Next-generation sequencing detection and characterization of a heterozygous novel splice junction mutation in the 2B domain of KRT1 in a family with diffuse palmoplantar keratoderma.

Santasree Banerjee1, Yunqing Ren, Tianying Wei, Zhongwei Zhou, Ping Yu, Fenghui Guan, Xiaonming Wei, Sheng Ye, Shaofeng Yan, Min Zheng, Michael L Raff, Ming Qi.   

Abstract

Diffuse palmoplantar keratoderma (DPPK) is an autosomal-dominant genodermatosis characterized by restricted, uniform hyperkeratosis on the palm and sole epidermis. DPPK is normally associated with dominant-negative mutations in the keratin-encoding gene, KRT1. We report a heterozygous novel point mutation in the exon 6 splice donor site of KRT1 (c.1254G>C) by next-generation sequencing, resulting in the formation of two alternative transcripts, which segregates with DPPK in a four-generation Chinese family. This results in both the complete loss of exon 6 and the simultaneous utilization of a novel in-frame splice site 54 bases downstream of the mutation with the subsequent deletion of 42 amino acids and the insertion of 18 amino acids into the protein's 2B domain. This is the first report of a novel splice donor site mutation with aberrant splicing and the formation of two alternative transcripts causing DPPK. This study also demonstrates the value of next-generation sequencing in the identification of novel disease-causing mutations.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  KRT1; alternative transcripts; diffuse palmoplantar keratoderma; next-generation sequencing; novel splice donor site mutation

Mesh:

Substances:

Year:  2015        PMID: 25429721     DOI: 10.1111/exd.12610

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  1 in total

1.  NGS in argininosuccinic aciduria detects a mutation (D145G) which drives alternative splicing of ASL: a case report study.

Authors:  Wei Wen; Dan Yin; Fangfang Huang; Meng Guo; Tian Tian; Hui Zhu; Yun Yang
Journal:  BMC Med Genet       Date:  2016-02-03       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.